These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy? Shulman LP J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108 [No Abstract] [Full Text] [Related]
23. [Hormonal contraceptives and their relationship to breast cancer]. Habánová M; Svikruhová J; Sláviková E Klin Onkol; 2010; 23(6):428-32. PubMed ID: 21351420 [TBL] [Abstract][Full Text] [Related]
24. After the Women's Health Initiative: decision making and trust of women taking hormone therapy. Schonberg MA; Davis RB; Wee CC Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110 [TBL] [Abstract][Full Text] [Related]
25. The History of Estrogen Therapy. Kohn GE; Rodriguez KM; Hotaling J; Pastuszak AW Sex Med Rev; 2019 Jul; 7(3):416-421. PubMed ID: 31147294 [TBL] [Abstract][Full Text] [Related]
27. Update in hormone therapy use in menopause. Taylor HS; Manson JE J Clin Endocrinol Metab; 2011 Feb; 96(2):255-64. PubMed ID: 21296989 [TBL] [Abstract][Full Text] [Related]
28. What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead? Simon JA Menopause; 2014 Jul; 21(7):769-83. PubMed ID: 24398406 [TBL] [Abstract][Full Text] [Related]
29. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM; Naftolin F; Brinton EA; Judelson DR Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [TBL] [Abstract][Full Text] [Related]
30. [Hormone replacement therapy and vessels: what's the story in 2007?]. Chabbert-Buffet N J Mal Vasc; 2007 Dec; 32(4-5):190-1. PubMed ID: 17698308 [No Abstract] [Full Text] [Related]
31. Is there a place for postmenopausal hormone therapy use in women with lupus? Gompel A; Piette JC Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529 [TBL] [Abstract][Full Text] [Related]
32. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Chu DZ J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103 [No Abstract] [Full Text] [Related]
33. Hormones and breast cancer. Wile AG; DiSaia PJ Am J Surg; 1989 Apr; 157(4):438-42. PubMed ID: 2648885 [TBL] [Abstract][Full Text] [Related]
34. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
35. [Female sex hormones increase the risk of breast cancer]. Vatten L Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837 [TBL] [Abstract][Full Text] [Related]
36. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?]. Bershteĭn LM Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027 [No Abstract] [Full Text] [Related]
37. Hormone therapy: the next chapter. Is it time to rewrite the book on postmenopausal hormone use? Harv Womens Health Watch; 2011 Mar; 18(7):1-3. PubMed ID: 21526525 [No Abstract] [Full Text] [Related]
38. Do female sex hormones initiate breast cancer? A review of the evidence. Wren BG Climacteric; 2004 Jun; 7(2):120-8. PubMed ID: 15497900 [TBL] [Abstract][Full Text] [Related]
39. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264 [TBL] [Abstract][Full Text] [Related]
40. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]